tiprankstipranks
Trending News
More News >
Positive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
PremiumRatingsPositive Clinical Data and Strategic Partnerships Drive Buy Rating for Nanobiotix
2M ago
Nanobiotix’s Strategic Partnership and Financial Stability Justify Buy Rating
Premium
Ratings
Nanobiotix’s Strategic Partnership and Financial Stability Justify Buy Rating
2M ago
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
Premium
Ratings
Nanobiotix’s Strategic and Financial Strength Bolstered by Janssen Licensing Agreement and Milestone Payments
2M ago
Nanobiotix downgraded to Neutral from Buy at UBS
PremiumThe FlyNanobiotix downgraded to Neutral from Buy at UBS
3M ago
Nanobiotix doses first patient in CONVERGE study
Premium
The Fly
Nanobiotix doses first patient in CONVERGE study
4M ago
Nanobiotix completes dose escalation-expansion parts  of NBTXR3  in PC
Premium
The Fly
Nanobiotix completes dose escalation-expansion parts of NBTXR3 in PC
5M ago
Nanobiotix provides update on NBTXR3 collaboration
PremiumThe FlyNanobiotix provides update on NBTXR3 collaboration
1y ago
Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study
Premium
The Fly
Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study
1y ago
Nanobiotix completes dose escalation of of radioenhancer NBTXR3 study
Premium
The Fly
Nanobiotix completes dose escalation of of radioenhancer NBTXR3 study
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100